Comprehensive multi-scale representation of disease mechanisms : the AsthmaMap example
Mardi 2 mai 2017 11:00
- Duree : 1 heure
Lieu : Salle de Conférence de l’IAB - Rond Point de La Chantourne, 38700 La Tronche (arrêt de tram Grand Sablon, ligne B)
Orateur : Alexander MAZEIN (EISBM, Lyon)
Background/Motivation
Large amount of high-throughput data become available in the effort to better understand complex diseases. Despite the availability of various approaches, tools for disease-specific functional analysis are greatly underdeveloped. The direct approach to solve this problem is developing highly accurate comprehensive computerized representations of disease mechanisms on the level of cellular and molecular interactions.
Results
We present the concept of disease maps as a large-scale community effort. We describe the AsthmaMap example, a conceptual model of asthma mechanisms that includes 3 interconnected layers of granularity with 22 cell types and more than 2000 of proteins involved. The intermediate and detailed layers are developed correspondingly in SBGN
Activity Flow and Process Description languages. This approach is designed to be used for data visualisation and interpretation on the level of signalling pathways and cell-tocell communication. While being complementary to generic pathway enrichment tools (g-Profiler, Ingenuity Pathway Analysis and MetaCore), a disease map focuses on
integrating information into a single flexible hierarchically-organised network, thus enabling advanced data analysis (e.g. via NaviCell, MINERVA) and making possible creating dynamic predictive computational models.
Conclusion
To progress with this approach we propose building on the best practices and lessons learned from the previous projects and applying shared standards, tools and protocols to generating high-quality representations and enabling the exchange of reusable pathway
modules (e.g. inflammation). We envision this strategy will facilitate powerful advances in systems medicine for understanding disease mechanisms, cross-disease comparison, finding disease comorbidities, suggesting drug repositioning, generating new hypotheses, and after careful validation, redefining disease ontologies based on their endotypes - confirmed molecular mechanisms.
Contact : karin.sadoul@univ-grenoble-alpes.fr
Prévenir un ami par email
Télécharger dans mon agenda